Loading clinical trials...
Loading clinical trials...
This is a Phase 1/2, open-label, dose-ascending, multicenter study of the safety and efficacy of LX2006 for participants who have Friedreich's Ataxia with evidence of cardiomyopathy. The study will ev...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lexeo Therapeutics
NCT06447025 · Friedreich Ataxia
NCT06054893 · Friedreich Ataxia
NCT06692296 · Friedreich Ataxia
NCT04577352 · Friedreich Ataxia
NCT04192136 · Friedreich Ataxia 1
Ataxia Center and HD Center of Excellence, University of California
Los Angeles, California
University of South Florida
Tampa, Florida
Mayo Clinic
Rochester, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions